Buyer's guide
Best clinical trial patient engagement,compared
Matching engines score who qualifies. Most eligible adults with cancer still never hear about a trial. The missing layer is the conversation that reaches them, screens them, and writes the outcome back.
HIPAA BAA · SOC 2 Type II · Adverse events routed
The short answer
Engagement is the gap, not matching
US adult cancer trial enrollment has sat near 3% to 5% for years. Identification systems can score thousands of records. Recruitment is whether a person is actually reached, in their language, before the window closes.
Decentralized trial platforms (Science 37, THREAD, Medable and peers) publish patient apps, ePRO, and televisits. Those are study-conduct tools. They do not, on the public record, run first-contact outreach across voice, text, and chat that writes status back to a hub or CRM.
Rivvi owns that conversation. Matching, including Massive Bio's prospectively validated oncology intelligence, decides who and why. Rivvi runs first contact, protocol pre-screening, and status write-back, and routes adverse events to the person you name. Clinical judgment stays with clinicians.
Side by side
Engagement layers, honestly compared
The columns that matter for a sponsor or hub: can you reach the matched patient today, and does the outcome land in your system of record.
rivviVoice + text + web chat
rivvi
YesTypical DCT platform
App / ePRO / televisit
Outsourced call center
Voice, staffed
First-contact outreach on a match list
rivvi
YesTypical DCT platform
Not stated
Outsourced call center
YesProtocol pre-screening in conversation
rivvi
YesTypical DCT platform
In-app / site
Outsourced call center
Scripted
Writes status back to hub or CRM
rivvi
YesTypical DCT platform
Not stated
Outsourced call center
Varies
Adverse events routed on every path
rivvi
YesTypical DCT platform
Not stated
Outsourced call center
Human flag
HIPAA BAA before patient data moves
rivvi
YesTypical DCT platform
Varies
Outsourced call center
Varies
Public pricing
rivvi
YesTypical DCT platform
NoOutsourced call center
NoSelf-serve trial for this job
Life sciences is enterprise-configured
rivvi
NoTypical DCT platform
NoOutsourced call center
NoCompetitor details are drawn from each vendor's public pricing and product pages as of July 2026 and may change. "Not stated" means the vendor does not publish that detail. Rivvi's free-trial details reflect the current published offer at rivvi.ai/pricing and rivvi.ai/sign-up.
Questions
Clinical trial engagement, answered
Is Rivvi a decentralized trial platform?
No. Rivvi is the engagement layer that sits after matching. DCT platforms run study conduct: apps, ePRO, televisits, and site workflows. Rivvi reaches the matched patient, runs pre-screening, and writes the outcome back. Sponsors keep their matching engine and their DCT stack.
How does the Massive Bio partnership fit?
Massive Bio provides prospectively validated oncology intelligence. Rivvi is the agentic action layer that turns each match into governed outreach and coordination. The announcement is on the Rivvi blog and the original Business Wire of August 4, 2026.
Do we start on the free trial?
Life sciences programs are enterprise-configured: protocols, AE routing, and hub write-back are set with you. The public 14-day trial is for self-serve practice and pharmacy work. Talk to us and we show the same engagement layer on your own candidate list.
Does Rivvi diagnose or enroll a participant?
No. Rivvi does not diagnose, prescribe, or override clinical judgment. Qualified participants route to the site or navigator you name. People who are not ready stay warm. Every action is governed, auditable, and written back.
More on how the rules bind: Security and compliance